Primus In News
Indian pharma ramps up US acquisitions amid regulatory and market shifts
15-03-2025
Nilaya Varma, CEO & Co-Founder, Primus Partners, and Vivek Tandon, Vice President, Primus Partners, share their view on the expansion of Indian pharmaceutical companies in the US through strategic acquisitions. They highlight Sun Pharma’s $355 million acquisition of Checkpoint Therapeutics as a key move to bolster its oncology and immunotherapy portfolio.
Explore Related Insights
- Indus Valley Urban Planning Can Fix India's Growing Urban Sprawl: Report
- Textile industry on recovery path as domestic demand improves
- Budget 2024 Expectations: Income tax rebate to home loan tax exemption. What ‘aam aadmi’ expects from FM Sitharaman
- RBI's newest pitch Unified Lending Interface: How will it revolutionise credit availability